Wells Fargo & Company »

Marker Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Marker Therapeutics (MRKR) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Marker Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Marker Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marker Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6k 283 5.51
2023-09-30 $1.3k 280 4.54
2023-06-30 $858 277 3.10

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Marker Therapeutics

NEA Management Company
Aisling Capital Management
Vanguard Group
Wedbush Morgan Securities
Dimensional Fund Advisors
Creative Planning
Matrix Asset Advisors
Advisor Group Holdings
Bank of America Corporation
Riggs Asset Managment
Us Bancorp
Wells Fargo & Company
Jpmorgan Chase & Co
Royal Bank of Canada
Versant Capital Management

View all funds holding Marker Therapeutics